On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
We have now added a new section called the "Assay History List" to the "At A Gla...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...